The Quality of Life in Multiple Sclerosis Patients Living in the North Region, Depending on Cognitive Status

10.12737/5911 ◽  
2014 ◽  
Vol 21 (3) ◽  
pp. 104-108
Author(s):  
Молчанова ◽  
Zh. Molchanova
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Cognitive Status ◽  
Rapid Progression ◽  
The North ◽  
Real Increase ◽  
The Central Nervous System ◽  
Assess Quality ◽  
Multiple Sclerosis Patients

Multiple sclerosis is the most frequent disease of the central nervous system. An increase in multiple sclerosis frequency was registered in several countries including Russia. This may be associated with better multiple sclerosis diagnosis and treatment, better data collection and real increase in multiple sclerosis incidence. Early disability and its rapid progression emphasize the medico-social importance of multiple sclerosis. Neuropsychological disturbances are often observed in multiple sclerosis, being one of the important components in the formation of clinical disease. 43 patients living in the North region with definite multiple sclerosis and mild or moderate disability were tested with expended neuropsychological, neurological and study of quality of life. The purpose of the study was to analyze the role of cognitive, emotional and personal peculiarities at multiple sclerosis on quality of life. To assess quality of life the authors used SF-36. The results of this study of quality of life revealed significant differences in the physical, role and social components depending on the cognitive peculiarities.

scholarly journals Evaluation of the effect of antispastic therapy in patients with multiple sclerosis based on the results of clinical and neurofunctional, neurophysiological and neuropsychological studies

2020 ◽  
pp. 18-24
Author(s):  
Nataliia Domres
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Effect Size ◽  
Invasive Technique ◽  
Euroqol 5D ◽  
Edss Score ◽  
Assess Quality ◽  
Pain Test ◽  
Multiple Sclerosis Patients

Objective: to conduct a comprehensive clinical and instrumental assessment of the effectiveness of antispastic therapy in multiple sclerosis patients. The observation of 68 patients with multiple sclerosis. The patients took three antispastic drugs — baclofen, thiocolchicoside (muscomed), tolperisone (midocalm). The degree of neurological deficit was assessed on the EDSS scale, the level of spasticity on the Ashworth scale, an electroneuromyographic study was performed using a stimulation non-invasive technique. Patients underwent a Timed-25-Footwalk test and a 9-Hole Peg Test. Patients completed questionnaires to assess quality of life (EuroQol-5D), fatigue (MFIS), pain (VAS). The assessment was carried out before treatment, after 10 days and after 2 months. In the group of patients who took thiocolchicoside, the total spasticity score was 12.87 ± 3.35, tolperisone — 14.17 ± 3.99, baclofen — 17.03 ± 3.74. 10 days after treatment, the total spasticity score decreased in all groups of patients. In the thiocolchicoside group the EDSS before treatment was 5.15 ± 0.88, tolperisone — 5.05 ± 0.63, baclofen — 5.68 ± 0.82. The effect size was strong in Cohen and Glass. After 10 days, the average EDSS score in the group of patients taking thiocolchicoside was 5.06 ± 0.85, tolperisone — 4.98 ± 0.56, baclofen — 5.55 ± 0.79 (p < 0.05). Ambulation scores were significantly improved in three groups of patients, which influenced the EDSS score. The studied drugs reliably reduce spasticity and improve the quality of life of patients, improve stroke rates, reduce fatigue and pain, test scores T25-FW, 9-HPT, the effect of treatment was stable during 2 months. Effect size measures were strong in total spasticity. When using thiocolchicoside, the M-amplitude indicator significantly increases in patients.

Quality of life in multiple sclerosis patients in Spain

2002 ◽  
Vol 8 (6) ◽  
pp. 527-531 ◽  
Author(s):  
C-H Chang ◽  
D Cella ◽  
O Fernández ◽  
G Luque ◽  
P de Castro ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Well Being ◽  
Cross Sectional Study ◽  
Self Report ◽  
Regression Analyses ◽  
Cross Sectional ◽  
Scale Scores ◽  
Multiple Sclerosis Patients

Objective: The cross-sectional study evaluated the psychometric properties of the Functional Assessment of Multiple Sclerosis (FAMS) Spanish version and its use in measuring quality of life (QOL) of multiple sclerosis (MS) patients in Spain. Methods: The FAMS is a factorially derived self-report scale designed to assess six primary aspects of QOL of patients with MS: Mobility, Symptoms, Emotional Well-Being, General Contentment, Thinking and Fatigue, and Family/Social Well-Being. Its Spanish translated version was used to assess QOL of 625 MS patients recruited in an outpatient clinic setting from 58 hospitals in Spain. Internal consistency of the Spanish FAMS was evaluated. Multiple regression analyses were performed to identify significant predictors from demographic, clinical and treatment characteristics, and Kurtzke Expanded Disability Status Scale (EDSS) scores in predicting FAMS scale scores. Results: Most of the patients are females (66%), and 74% were of the relapsing-remitting (RR) clinical subtype. Cronbach’s alpha coefficients were high (range=0.78-0.96), indicating subscale homogeneity comparable to that of the original English version. Linear multivariate regression analyses revealed that the EDSS is a dominant variable in predicting all the FAMS subscales, especially mobility (R2=0.51) and the total scores. Conclusions: The Spanish FAMS is a psychometrically valid instrument that allows clinicians and clinical researchers the ability to measure the QOL concerns of MS patients in Spain.

Fatigue, mood and quality of life improve in MS patients after progressive resistance training

2010 ◽  
Vol 16 (4) ◽  
pp. 480-490 ◽  
Author(s):  
U. Dalgas ◽  
E. Stenager ◽  
J. Jakobsen ◽  
T. Petersen ◽  
HJ Hansen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Resistance Training ◽  
Beneficial Effect ◽  
Control Group ◽  
Progressive Resistance Training ◽  
Multiple Sclerosis Patients ◽  
Progressive Resistance

Fatigue occurs in the majority of multiple sclerosis patients and therapeutic possibilities are few. Fatigue, mood and quality of life were studied in patients with multiple sclerosis following progressive resistance training leading to improvement of muscular strength and functional capacity. Fatigue (Fatigue Severity Scale, FSS), mood (Major Depression Inventory, MDI) and quality of life (physical and mental component scores, PCS and MCS, of SF36) were scored at start, end and follow-up of a randomized controlled clinical trial of 12 weeks of progressive resistance training in moderately disabled (Expanded Disability Status Scale, EDSS: 3—5.5) multiple sclerosis patients including a Control group ( n = 15) and an Exercise group ( n = 16). Fatigue (FSS > 4) was present in all patients. Scores of FSS, MDI, PCS—SF36 and MCS—SF36 were comparable at start of study in the two groups. Fatigue improved during exercise by —0.6 (95% confidence interval (CI) —1.4 to 0.4) a.u. vs. 0.1 (95% CI —0.4 to 0.6) a.u. in controls ( p = 0.04), mood improved by —2.4 (95% CI —4.1 to 0.7) a.u. vs. 1.1 (—1.2 to 3.4) a.u. in controls ( p = 0.01) and quality of life (PCS—SF36) improved by 3.5 (95% CI 1.4—5.7) a.u. vs. —1.0 (95% CI —3.4—1.4) a.u. in controls ( p = 0.01). The beneficial effect of progressive resistance training on all scores was maintained at follow-up after further 12 weeks. Fatigue, mood and quality of life all improved following progressive resistance training, the beneficial effect being maintained for at least 12 weeks after end of intervention.

Memory performance in multiple sclerosis patients correlates with central brain atrophy

2006 ◽  
Vol 12 (4) ◽  
pp. 428-436 ◽  
Author(s):  
H Hildebrandt ◽  
H K Hahn ◽  
J A Kraus ◽  
A Schulte-Herbrüggen ◽  
B Schwarze ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Brain Atrophy ◽  
Motor Performance ◽  
Memory Performance ◽  
Cognitive Tests ◽  
Duration Of Symptoms ◽  
Central Brain ◽  
Multiple Sclerosis Patients

Objective To assess whole brain and central brain atrophy as well as their differential relation to memory, cognitive performance, fatigue, depression and quality of life in patients with relapsingremitting multiple sclerosis (RRMS). Methods A 3D flow compensated gradient recalled T1-weighted MRI was acquired in 45 RRMS patients. An automated analysis tool was used to calculate brain parenchymal fraction (BPF) and ventricular brain fraction (VF). All patients were assessed with neuropsychological tests focusing on memory and self-rating scales for depression, fatigue and quality of life. Age corrected partial correlations between brain atrophy, motor performance, psychological scales and test scores were calculated. Results BPF correlated moderately (0.35≤r<0.5) with duration of symptoms and disease, the Expanded Disability Status Scale (EDSS), the upper extremity motor performance, and with mental aspects of quality of life. VF correlated moderately with EDSS, upper and lower extremity motor performance and memory functions. Neither BPF nor VF correlated with fatigue and depression. Results of several cognitive tests correlated moderately with depression and fatigue, the Paced Auditory Serial Addition Test (PASAT) showing the largest correlation. Conclusions Memory performance shows a correlation with relative ventricular size in RRMS patients, indicating the strategic location of the ventricle system along the structures of the limbic system and its vulnerability in MS. The PASAT and several other cognitive tests show moderate correlations with depression and fatigue, arguing for an inter relation between the cognitive functioning and the emotional state of patients. However, this relation is independent of measurable brain atrophy.

Quality of life of multiple sclerosis patients with comorbid migraine

2011 ◽  
Vol 32 (S1) ◽  
pp. 149-151 ◽  
Author(s):  
Veronica Villani ◽  
L. Prosperini ◽  
C. Pozzilli ◽  
M. Salvetti ◽  
G. Sette
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Multiple Sclerosis Patients

Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis

2007 ◽  
Vol 13 (1) ◽  
pp. 106-112 ◽  
Author(s):  
M W Nortvedt ◽  
T Riise ◽  
J Frugaård ◽  
J Mohn ◽  
A Bakke ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Bowel Dysfunction ◽  
Sexual Problems ◽  
Health Related Quality ◽  
Related Quality ◽  
Bowel And Bladder Dysfunction ◽  
Health Related ◽  
Multiple Sclerosis Patients

Most multiple sclerosis (MS) patients experience some sexual, bladder and/or bowel dysfunction during the course of the disease - one of MS most disabling features. This study estimated the frequency of these problems among patients, two to five years after diagnosis, and investigated how these problems are associated with health-related quality of life (using the Multiple Sclerosis Quality of Life-54 questionnaire). The study population comprised a cohort of patients (n=56), diagnosed in a three-year period, in Hordaland County, Norway. The patients were examined clinically, including scoring of the Expanded Disability Status Scale (EDSS), and completed questionnaires related to bowel and bladder dysfunction, sexual problems and health-related quality of life. More than half the patients had bladder and sexual problems. The frequency of self-reported bladder problems corresponded to the relatively high levels of residual urine found. The presence of these problems was associated with lower scores on the quality of life scales. Further, the bowel problems reported were markedly associated with the quality of life scores. Since treatments and preventive strategies can manage many of these problems, we suggest increasing the focus on these aspects of the disease when consulting patients, including at early stages.

scholarly journals Is the Concept of Quality of Life Relevant for Multiple Sclerosis Patients with Cognitive Impairment? Preliminary Results of a Cross-Sectional Study

PLoS ONE ◽  
2012 ◽  
Vol 7 (1) ◽  
pp. e30627 ◽  
Author(s):  
Karine Baumstarck ◽  
Jean Pelletier ◽  
Valérie Aghababian ◽  
Françoise Reuter ◽  
Irina Klemina ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Cognitive Impairment ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Preliminary Results ◽  
Multiple Sclerosis Patients

Impact of anger on the health-related quality of life of multiple sclerosis patients

2014 ◽  
Vol 21 (5) ◽  
pp. 630-641 ◽  
Author(s):  
Andrés Labiano-Fontcuberta ◽  
Alex J Mitchell ◽  
Sara Moreno-García ◽  
Verónica Puertas-Martín ◽  
Julián Benito-León
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Anger Expression ◽  
Health Related Quality ◽  
Psychotherapeutic Interventions ◽  
Related Quality ◽  
Health Related ◽  
Multiple Sclerosis Patients ◽  
Study Participants

Background: There is evidence of the presence of a disturbed pattern of anger in multiple sclerosis (MS). Emotion changes, including anger, are thought to influence health-related quality of life (HRQoL). However, although deleterious consequences of anger on physical health have been well reported, there are no studies that have analysed the effects of anger on the HRQoL in patients with MS. Our purpose was to assess the extent to which anger impacts on the HRQoL of a cohort of MS patients. Methods: One hundred and fifty-seven consecutive MS patients were enrolled in the study. Participants were administered affective trait measures (Beck Depression Inventory, Beck Anxiety Inventory) and anger measures (the Spanish adapted version of the State-Trait Anger Expression Inventory-2). HRQoL was quantified using the Functional Assessment of MS. Results: Linear regression analyses revealed that even after controlling for socio-demographic and clinical variables, higher levels of anger expression-in (tendency to handle anger by keeping it inside) independently predicted worse overall HRQoL of MS patients (β = −0.15, p = 0.04). We further found that this relationship was moderated by gender, showing that anger expression-in is a more influential predictor of the HRQoL in women with MS. Conclusion: The present study provides evidence that anger negatively affects the HRQoL of MS patients. Our results may have implications for those involved in treating emotional complications of MS and especially regarding psychotherapeutic interventions to improve HRQoL of MS patients.

Sign in / Sign up

Export Citation Format

Share Document